Cargando…
Diabetic Ketoacidosis and Profound Insulin Resistance From Brentuximab Vedotin
Hodgkin’s lymphoma is commonly treated with a combination of chemotherapy drugs including doxorubicin, bleomycin, vinblastine, and dacarbazine. Antibody-drug conjugates such as brentuximab vedotin are now being used to treat Hodgkin’s lymphoma that has not responded to standard treatment. Brentuxima...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074015/ https://www.ncbi.nlm.nih.gov/pubmed/37025732 http://dx.doi.org/10.7759/cureus.35804 |